Cadrenal Therapeutics Total Risk Alpha
| CVKD Stock | | | 7.70 0.30 4.05% |
The Total Risk Alpha technical lookup provides context for Cadrenal Therapeutics Common and related instruments. Data availability can vary by region and feed;
Equity Screeners provides broader screening access. Cadrenal Therapeutics has a market cap of 17.3 M, ROE of -4.68%. Review
Trending Equities for broader portfolio context. This reflects a position in Cadrenal Therapeutics Common within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in industry.
Cadrenal Therapeutics Common has current Total Risk Alpha of 0.2328. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.
Total Risk Alpha | = | RFR + (ER[b] - ER[a]) | x | STD[a] / STD[b] |
| = | 0.2328 | |
| ER[a] | = | Expected return on investing in Cadrenal Therapeutics |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on Cadrenal Therapeutics |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
Cadrenal Therapeutics Total Risk Alpha Peers Comparison
Cadrenal Total Risk Alpha Relative To Other Indicators
Cadrenal Therapeutics Common is rated
below average for total risk alpha relative to top peers. It is currently under evaluation for maximum drawdown relative to top peers with a Maximum Drawdown-to-Total Risk Alpha ratio near
191.58 . The Maximum Drawdown to Total Risk Alpha ratio for Cadrenal Therapeutics Common comes in at
191.58 The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.